News Details

(As on May 23, 2025, 11:58)

Back

Alembic Pharmaceutic - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2025, titled ""Alembic Pharmaceuticals receives USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg"".

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING